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Abstract: Primary ciliary dyskinesia (PCD) is a rare inherited condition affecting motile cilia and
leading to organ laterality defects, recurrent sino-pulmonary infections, bronchiectasis, and severe
lung disease. Research over the past twenty years has revealed variability in clinical presentations,
ranging from mild to more severe phenotypes. Genotype and phenotype relationships have emerged.
The increasing availability of genetic panels for PCD continue to redefine these genotype-phenotype
relationships and reveal milder forms of disease that had previously gone unrecognized.
Keywords: primary ciliary dyskinesia; molecular genetics; genotype-phenotype association
1. Introduction
Motile ciliopathies are a group of disorders where motile cilia lining embryonic cells,
airways, sinus and inner ear cavities, and ventricles in the brain are dysfunctional. The
primary function of these hair-like projections is to facilitate the movement of fluid (i.e.,
mucus that lines the airways, cerebrospinal fluid) within various body cavities to be either
recirculated or expelled [1]. Research into the structure and function of cilia in the last
two decades has provided insights into the complex arrangement of the individual cilia
components, and how genetic variation impacts component assembly and subsequent cilia
function. This review will provide an overview of cilia structure and function, the genes
involved in cilia assembly, and the phenotypic consequences of genetic variants in primary
ciliary dyskinesia (PCD).
2. Overview of Primary Ciliary Dyskinesia
Presenting frequently in an autosomal recessive manner, PCD is a rare inherited
disorder of motile cilia with an estimated incidence of 1:10,000 to 1:20,000 [2]. The condition
typically presents early in life, with many infants experiencing respiratory distress at birth
despite being born at term [3]. Symptoms of PCD are directly related to ineffective or absent
beating of motile cilia in the embryonic node, respiratory, reproductive, and neurologic
systems. This dysfunction results in impaired mucus clearance in the airways, abnormal
sperm movement, or altered fluid flow in the fallopian tubes and ventricles within the brain.
Affected people can present with a variable phenotype that can be severe or mild, leading
to diagnostic challenges. Symptoms include chronic daily wet cough, chronic rhinorrhea,
recurrent sinusitis, recurrent otitis media, bronchiectasis, infertility (or subfertility), situs
abnormalities, and rarely hydrocephalus [4]. Sino-pulmonary symptoms are typically
the most common manifestations of the condition. Approximately fifty percent of people
with PCD will present with situs inversus, and heterotaxy is more common in this disease.
Practitioners who see people with these complaints should have a high degree of suspicion
for PCD so early identification and diagnostic testing can be performed.
Int. J. Mol. Sci. 2021, 22, 8272. https://doi.org/10.3390/ijms22158272 https://www.mdpi.com/journal/ijms
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3. Cilia Structure and Function
3.1. Overview
Cilia are organized structures of microtubules which protrude from the cell surface,
serving many physiologic functions. Cilia are grouped into categories as motile or non-
motile, and can have either a 9+2 or 9+0 arrangement of microtubule doublets (Figure 1) [1].
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Motile cilia possessing the 9+2 arrangement re found primarily in the upper and
lower respiratory tract, female reproductive tract, and spermatozoan. The primary function
of motile cilia with the 9+2 arr ngement is to move liquid and/or mucous pa allel to the
cells’ surface or in the case of spermatozoan flagellum, th se cilia lead to the propulsion
of the sperm. Motile cilia possessing the 9 0 are found in the embryonic
node and play a primary role in determining l ft-right asymmetry of organs during human
development by directing fluid flow across the cell surface [5]. This is achi ved through a
rotational motion of the cilium, which contrasts to the “wave-like” motion of the motile
9+2 cilia. Finally, primary cilia are usually solitary, nonm tile o ganelles that typically have
a “9+0” microtubule configur . Present on the surface of most n -dividing c lls, these
structures sense the extracellular environment. Addition lly, they regulate devel p ental
pathways, and defects lead to a growing num er of complex clinically varied conditions.
Affected individuals can have diverse features, such as variable mental disabilities, skeletal
anomalies, obesity, retinal dege eration, and polycystic kidneys [6]. While overlapping
conditions have been described, the role of these structures is not in fluid movement and
thus are not directly implicated in the pathogenesis of motile ciliopathies [7].
3.2. Respiratory Cilia
Cilia lining the upper and lower respiratory tracts have a 9+2 configuration of micro-
tubules that extend from the apical cell surface. Hundreds of these cilia are present on
each ciliated cell and they move in a coordinated fashion, leading to effective mucociliary
clearance or movement of mucus from the lower to the upper respiratory tract, out of the
sinus ostia, or out of the middle ear space. The cilia structure is stabilized by hundreds of
proteins whose alteration can produce the phenotype seen in PCD. A normally structured
cilium shows an arrangement of nine microtubule doublets that are arranged along the
circumference of the cilia along with another pair in the center referred to as the central
apparatus or central complex. The outer doublets are anchored to the central complex by
radial spoke proteins and anchored to one another by dynein and nexin proteins. This
anchoring of microtubules by radial spoke and dynein-nexin complexes occurs very specif-
ically, every 96 nanometers along the length of a cilium [8]. This prescribed repetition is
key for generating an effective cilia waveform and motion.
The outer dynein arm is a motor complex which drives cilia beating [9], and is
regulated by signals from the central apparatus and nexin-dynein regulatory complex, a
group of proteins essential in determining cilia axonemal waveform [1]. Attachment of
outer doublets to the central complex not only provides structure, but the central complex
also relays mechanosensory signals to the outer doublet arms [10]. This information is
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essential for coordination of cilia motion and cilia lacking proper radial spoke protein
assembly may have stiff and ineffective beating [11].
In addition to the proteins which make up the structural components of the cilia, there
is a group of pre-assembly factors that are crucial to proper cilia assembly but reside in the
cytoplasm and not in the cilia itself [12]. This large group is thought to play key roles in
assembly of components in the cilia prior to their transport into a newly growing cilium.
Basal bodies are an additional important structure in the growth of new cilia. The basal
bodies consist of transition fibers necessary for intraflagellar transport and give rise to basal
feet to help anchor the growing cilium [1]. Basal feet must retain a typical orientation to
produce coordinated movement in multiciliated cells, and variation in proteins interacting
with basal feet can alter this orientation and produce a PCD phenotype [13]. Genetic
variants in pre-assembly proteins and their effects on cilia motion and effective beating is
an area of ongoing research
4. Diagnosis
PCD is a complex and genetically heterogeneous disorder requiring multiple ap-
proaches for confirmatory diagnosis. There is not a single gold-standard test for the diagno-
sis of PCD. Two guideline statements outline potential strategies for clinicians [14,15]. The
diagnostic toolkit includes medical history, transmission electron micocroscopy (TEM) for
analysis of cilia ultrastructure, and genetic testing. Nasal nitric oxide (nNO) measurements
can be a useful adjunctive test, provided cystic fibrosis has been excluded. However,
reduced nNO levels alone are insufficient to make the diagnosis of PCD. People with motile
ciliopathies who have mutations in some disease-associated genes can have nNO measure-
ments that fall in a non-diagnostic range (Tables 1 and 2). Availability of diagnostic tools
also vary among sites, depending on the resources and experience of the institution. For
instance, high-speed video microscopy is considered a diagnostic test in some European
centers, but due to the lack of standardization and subjectivity, this tool is primarily used
only on a research basis in the North America. Immunofluorescence staining of ciliated
epithelial cells in vitro can also detect cilia abnormalities, and this technique is increasingly
being used as a clinical diagnostic, replacing TEM in many European centers. However, it
has not been widely adopted in North America.
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Table 1. Genes, clinical features, and diagnostic measures described in people with primary ciliary dyskinesia and normal or near-normal ciliary ultrastructure.
Gene nNO Motility Respiratory Symptoms Laterality Defects Subfertility
DNAH1 [16,17] NR NR Yes Yes Yes
DNAH9 [18,19] Low or Normal Hypokinetic or reduced distal bending Yes Yes Yes
DNAH11 [20,21] Low Hyperkinetic Yes Yes Yes
DNAH17 [22] NR NR NR NR Yes
LRRC56 [23] Low Immotile, stiff, or twitching Yes Yes NR
GAS2L2 c [13] Low or normal Hyperkinetic Yes NR NR
HYDIN [21,24,25] Low or normal Immotile, rigid, rotational Yes NR Yes
CFAP221 [26] Normal Circular pattern Yes NR NR
SPEF2 [24] Low Stiff, rotational pattern Yes NR Yes
STK36 [27] Normal Stiff Yes NR Yes
CCDC164 [28,29] Low Stiff Yes NR NR
CCDC65 [30,31] Low Stiff, hyperkinetic Yes NR NR
GAS8 [21,32,33] Low or normal Normal or subtle beat abnormality Yes NR Yes
RSPH1 a [21,34] Low or normal Reduced bending angle Yes NR Yes
RSPH3 a [21,35] Low Reduced bending angle Yes NR Yes
RSPH4A a [21,36–39] Low or Normal Rotational pattern, stiff Yes NR NR
RSPH9 a [11,21,36,40] Low or Normal Rotational pattern, stiff Yes NR Yes
DNAJB13 [41] Low Reduced amplitude Yes NR Yes
CFAP53 [42] Normal Normal Yes Yes NR
NEK10 b [43] Normal Normal Yes NR NR
OFD1 [44,45] Low Normal, immotile, or stiff Yes Yes NR
NME5 d [46] NR NR Yes NR NR
RPGR e [47,48] Normal Normal or uncoordinated Yes NR NR
Normal nNO is >77 nL/min; NR—Not reported in literature; Footnotes: a Absent or defective radial spokes may be an acquired defect; b Shortened cilia; c Disoriented cilia; d Absent central pair; e X-linked
transmission.
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Table 2. The relationship between specific genes, ultrastructural defects, other diagnostic measures, and clinical features in primary ciliary dyskinesia.
Ultrastructure Gene nNO Motility Respiratory Symptoms Laterality Defects Subfertility
Outer dynein arm defect DNAH5 [21,49–51] Low Immotile or stiff Yes Yes Yes
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Table 2. Cont.
Ultrastructure Gene nNO Motility Respiratory Symptoms Laterality Defects Subfertility
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5. Genotype and Phenotype Associations
5.1. Genotype Associations Based on Clinical Symptoms
Classic descriptions of PCD have focused on recurrent pulmonary infections and situs
anomalies as the predominant presenting features. Four key clinical features characteristic
of PCD have been reported and were incorporated in the American Thoracic Society
clinical guidelines [87]. A positive answer to at least two of the four clinical features greatly
increases the specificity and sensitivity of diagnosis. The features are: (1) unexplained
neonatal respiratory distress in a term infant; (2) chronic wet coughing beginning at less
than six months of age; (3) chronic daily nasal congestion beginning at less than six months
of age; and (4) abnormalities of organ left-right asymmetry. Additional clinical features
not listed but often present in PCD are chronic otitis media with middle ear effusion, and
subfertility of both males and females owing to dysmotility of sperm or fallopian tube cilia.
Clinical features associated with specific genotypes may vary widely, leading to
difficulties in identifying people with PCD. The severity of the manifestations associated
with airway diseases can depend on the genetic variant encountered. People who have
pathogenic variants in the genes DNAH11 [20], DNAH9 [18], and RSPH1 [88] can have
milder respiratory symptoms. In particular, people with biallelic RSPH1 mutations have
lower prevalence of neonatal respiratory distress, later onset of cough, and better lung
function (FEV1) compared to age- and sex-matched cases.
Roughly half of people with PCD have situs abnormalities [89]. Although many
components of the 9+2 arrangement in motor cilia are shared with the 9+0 arrangement in
primary cilia, a genetic variant producing a phenotype in one type of cilia do not necessarily
produce a phenotype in the other type of cilia. This is clearly illustrated in genes which
encode structures integral for the development of the central complex and radial spokes.
Since the 9+0 primary cilium does not have a central complex and radial spokes, it is not
surprising that alterations in those genes do not affect nodal cilia development or function.
Examples of this phenomenon include variants involved in structure of the radial spoke
proteins encoded by RSPH1 [88], RSPH3 [35], RSPH4A [36–38], and RSPH9 [36] and those
in the central tubule pair such as HYDIN [25], SPEF2 [24], and STK36 [27]. Individuals
with these genetic variants are not reported to have left-right laterality defects.
An important relationship between genotype and phenotype exists in the reproductive
tract. The sperm flagellum possesses a 9+2 arrangement of microtubules and shares many
proteins with motile cilia in the respiratory tract. In addition the luminal cells of the
fallopian tube possess motile cilia to help move the ovum towards the uterus. There
are reports of fertility for both males and females who have variants in outer dynein
arm proteins encoded by DNAH5 [50], DNAH11 [21], and CCDC114 [58], along with
radial spoke proteins encoded by RSPH4A [21,36]. While these few patients illustrate the
possibility of fertility in PCD patients, many people with PCD will experience infertility or
subfertility [21].
5.2. Genotype Associations with Cilia Ultrastructrual Abnormalities
The variable association of clinical features with PCD genotypes also holds true for
cilia ultrastructure. Transmission electron microscopy (TEM) provides an important tool
in diagnosis of PCD, but cannot be relied upon as a gold standard due to the presence of
normal cilia ultrastructure observed with many genetic variants [90] (Table 1). However,
some genetic variants have obvious ultrastructural abnormalities (Table 2).
Microtubular disorganization associated with inner dynein arm and central apparatus
defects are associated with variation in the genes CCDC39 and CCDC40. The products of
these two genes interact with one another and their proteins are intertwined in a braided
fashion along the axoneme. They are critical for microtubule organization and accurate
spacing of the inner dynein arm complexes every 96 nm [8]. Both gene products must
be functional for normal cilia assembly, and a defect in one of these proteins cannot be
compensated by a functional counterpart [80,91]. Notably, studies have shown that children
who have biallelic mutations in CCDC39 or CCDC40 have nutritional deficits, greater lung
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disease, and more rapid pulmonary function decline when compared with individuals with
other ultrastructural defects [80,91,92]. A brief report also suggested that both men and
women who have these genetic and ultrastructural defects are more likely be infertile [21].
The most common cilia ultrastructure anomaly described is absence of the outer
dynein arm. This finding is reported to occur in at least 20 of the ~50 published genes [92].
Structural proteins (DNAH5, DNAI1, DNAI2, NME8) [50,52,53,56], dynein arm docking
complexes (CCDC114, CCDC151, ARMC4, TTC25) [57,59,61,62], and attachment factor
CCDC103 [43] all routinely demonstrate absence of outer dynein arms. Cytoplasmic dynein
assembly factor proteins (DNAAF1, DNAAF2, DNAAF3, DYX1C1, HEATR2) [69,71,73,76]
have also been reported to have absence of outer dynein arms but this nearly always
accompanies a loss of the inner dynein arm as well. Interestingly, the specific variant
observed in a given gene can be responsible for different phenotypes. The p.Gly128fs25*
variant of CCDC103 produces a loss of the outer dynein arm, while the p.His154Pro variant
has a variety of presentations ranging from normal ultrastructure to complete loss of outer
dynein arms [64]. Research into variant specific phenotypes is an area of ongoing study.
Patients with radial spoke gene variants may have variable clinical presentations
with mild or severe respiratory symptoms, and situs solitus. TEM alterations associated
with RSPH1 [88], RSPH3 [35], RSPH4A [36], RSPH9 [36], and DNAJB13 [41] variants
all show absence of the radial spoke apparatus, along with abnormalities in the central
pair itself. The absence of radial spokes or central complex defects are not independently
diagnostic for PCD, since these abnormalities have been found in the cilia of healthy control
subjects. Clinical correlation and additional testing are recommended when encountering
this ultrastructural finding [93]. While absence of radial spokes in respiratory cilia may
produce a relatively mild phenotype, the absence of those same structures in the sperm tail
is sufficient to lead to infertility [41].
There are a group of genes present in various parts of the cilium that when altered,
produce no obvious ultrastructural abnormalities (Table 1). Examples of these include
genes producing inner proteins of the microtubule (CCDC11) [42], nexin-dynein regula-
tory complex proteins (DRC1, GAS8) [29,33], and outer dynein arm proteins (DNAH9,
DNAH11) [18,20]. While evaluation by transmission electron microscopy is an important
diagnostic tool, the finding of normal or near-normal ciliary ultrastructure does not exclude
the disease. Approximately 30% of people with PCD can have normal or near-normal
axonemal structure [94].
5.3. Genotype Associations with Nasal-Nitric Oxide Values
Nasal nitric oxide is an important adjunctive test when evaluating people for possible
PCD. This test has shown a reliable segregation of values when comparing individuals
with PCD to those who do have this disease [95]. While this test is reported to have a
sensitivity of 0.98 and a specificity of up to 0.99 in select populations, there remains a rare
number of individuals diagnosed with PCD who retain a normal nNO value of >77 nL/min
(Tables 1 and 2). Generally speaking, genes which produce a more subtle clinical phenotype
are associated with normal nNO values. Examples include RSPH1 [88], RSPH4A [39],
RSPH9 [39], DNAH9 [18], GAS2L2 [13], HYDIN [25], CFAP53 [42], NEK10 [43], RPGR [47],
STEK36 [27], CFAP221 [26], TTC12 [82], CCDC103 [64], and FOXJ1 [86]. Thus, while most
people with PCD have reduced nNO levels, normal values do not exclude the disease,
especially in people who have characteristic clinical features. A low nNO concentration
warrants continued evaluation for PCD, provided cystic fibrosis has been excluded. It is
also important to note that people with primary immunodeficiencies, conditions that have
clinical features that overlap with PCD, can have reduced nNO levels and further testing
may be needed [96].
5.4. Genotype Associations with Cilia Beating Abnormalities
A critical function of motile cilia in the respiratory tract is not simply their ability
induce particle motion in the immediate area, but to do so in a coordinated fashion; thereby,
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leading to appropriate mucociliary clearance. Lack of effective cilia beat leads to decreased
mucus clearance and the sequelae of recurrent lung infections, airway obstruction, and
eventual bronchiectasis. Multiple genetic variations have been described which produce
absent or ineffective beating patterns which are best assessed using high speed video
microscopy (HSVM). One widely recognized pattern is the phenotype of the stiff and fast
beating cilium. GAS2L2 has been found to produce this phenotype with a beat frequency
faster than baseline (19.8 Hz v 15.8 Hz) and ineffective coordination of the cilia due to
abnormal cilia orientation [13]. Hyperkinetic and stiff beating cilia is also noted with those
who have a variant in the outer dynein arm gene DNAH11 [97]. A large number of proteins,
notably those involved in cytoplasmic dynein assembly, have evidence of non-motile cilia
when viewed under HSVM. The non-motile phenotype extends to other proteins involved
in the outer dynein arms such as the outer dynein arm protein DNAH5 and intermediate
light chain proteins DNAI1, DNAI2, [28]. This group has been noted to display both
non-motile but also flickering cilium with beat frequencies that are less than 5 Hz, well
below the frequency of a healthy control.
A third group of genes produce a decreased number of cilia on the cell surface.
These genes are fundamental to ciliogenesis and genetic variation produces a classic PCD
phenotype. Included in this group are CCNO [84] and MCIDAS [85] as genes which
have been identified as important in the cell cycle and serve to differentiate airway stem
cells into ciliated cells. Mutations in a key transcription factor that regulates cilia gene
expression, FOXJ1, also reduce the number of motile cilia, and are clinically associated
with hydrocephalus, recurrent respiratory infections, and laterality defects [86].
5.5. Genotype Associations with Non-Respiratory Syndromes
The overlap in proteins that underlie the structure of both motile and non-motile
cilia creates the opportunity for overlapping of symptoms between various syndromes.
A primary example of this is variants in RPGR where some individuals develop ocular
symptoms, respiratory symptoms, and situs anomalies as a result of this shared protein
product in ocular and respiratory cilia [48]. Neurologic manifestations such as intellectual
disability, hydrocephalus or ventriculomegaly are increasingly seen in people with over-
lapping features of motile and primary ciliopathies. Individuals with one or more of these
symptoms can have variants in the genes OFD1, MCIDAS, or FOXJ1 [45,86,98]. Indeed,
single mutations in FOXJ1, a transcription factor that regulates cilia gene expression, re-
duce the number of motile cilia, and clinically associated with hydrocephalus, recurrent
respiratory infections, and laterality defects [86]. Individuals with homozygous loss of
function variants in a recently reported gene, TP73 have recurrent respiratory infections,
bronchiectasis, and lissencephaly but interestingly do not have situs abnormalties [99].
Despite the large number of proteins shared between motile and immotile cilia struc-
tures, the overlap of neurologic, ocular, and respiratory symptoms remains rare. These
overlapping syndromes are an area of ongoing research.
6. Conclusions
Primary ciliary dyskinesia is a rare, inherited disorder characterized by impaired cil-
iary function leading to chronic sinopulmonary disease, persistent middle ear involvement,
laterality defects, and subfertility. During the past two decades, we have gained greater un-
derstanding of the genetic and pathophysiologic bases of PCD. Indeed, research has shown
a clinical spectrum of motile ciliopathies, far broader that the classical form described by
Kartagener nearly 90 years ago [100]. The development of powerful molecular biology
and gene sequencing tools have allowed investigators to discover new genes, determine
how encoded proteins are involved in ciliary structure and function, and produce model
systems that have been invaluable in defining this disease. Along with the creation of
multicenter clinical consortia, these tools have allowed us to identify and characterize
various genotype-phenotype associations in PCD. While some of these relationships have
yet to be fully defined, they serve as a general guide for clinicians and researchers who are
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trying to understand what has become an increasingly complex disease. While pathogenic
variants in some genes can produce milder clinical symptoms, mutations in others produce
severe clinical phenotypes and a potentially life shortening disease course. A high degree
of suspicion and thorough evaluation utilizing multiple diagnostic methods are key to
changing outcomes in PCD.
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